| Magnet System Gastric Outlet Obstruction Study (NCT07609511) | GT Metabolic Solutions, Inc. | 2026-07-01 |
| Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes (NCT07317115) | GT Metabolic Solutions, Inc. | 2026-03-18 |
| Creation of Compression Anastomosis Using the GT Metabolic Magnet System (NCT07431723) | GT Metabolic Solutions, Inc. | 2026-02-16 |
| GT Metabolic Magnet System in Adults With Gastrointestinal Disorders (NCT07317076) | GT Metabolic Solutions, Inc. | 2025-12-09 |
| Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System in Mexico (NCT07085741) | GT Metabolic Solutions, Inc. | 2025-05-07 |
| MagDI U.S. Registry (NCT06928545) | GT Metabolic Solutions, Inc. | 2025-03-28 |
| Magnetic Duodeno-Ileal Chile Study (NCT06613724) | GT Metabolic Solutions, Inc. | 2024-10-14 |
| MagDI Italian Study (NCT06613711) | GT Metabolic Solutions, Inc. | 2024-09-20 |
| MagDI Australia Study (NCT06473831) | GT Metabolic Solutions, Inc. | 2024-08-13 |
| MagDI Canada Study (NCT06467955) | GT Metabolic Solutions, Inc. | 2024-05-10 |
| Magnetic Jejuno-Ileal Diversion Study ("MJI Study") (NCT06232746) | GT Metabolic Solutions, Inc. | 2024-02-13 |
| Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study") (NCT06073457) | GT Metabolic Solutions, Inc. | 2023-11-06 |
| MagDI Diversion Feasibility Study (NCT05692518) | GT Metabolic Solutions, Inc. | 2022-12-19 |
| Creation of Side-to-Side Compression Anastomosis Using the Magnetic Anastomosis System (NCT05322122) | GT Metabolic Solutions, Inc. | 2021-11-18 |